BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), a leader in AI-driven drug discovery, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York City. The company's CEO, Vin Singh, will deliver a presentation that will be available on demand starting September 9, 2024, at 7:00am ET. Interested parties can access live and archived webcasts of the event through BullFrog AI's investor relations website at investors.bullfrogai.com. This participation provides an opportunity for the company to showcase its advancements in AI-driven drug discovery to a global investment audience.
BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), leader nella scoperta di farmaci basata sull'AI, ha annunciato la sua partecipazione alla 26esima Conferenza Annuale Globale sugli Investimenti H.C. Wainwright a New York. Il CEO dell'azienda, Vin Singh, presenterà un intervento che sarà disponibile on demand a partire dal 9 settembre 2024, alle 7:00 ET. Le parti interessate possono accedere alle trasmissioni in diretta e alle registrazioni dell'evento tramite il sito web per gli investitori di BullFrog AI all'indirizzo investors.bullfrogai.com. Questa partecipazione offre all'azienda l'opportunità di mostrare i suoi progressi nella scoperta di farmaci assistita dall'AI a un pubblico globale di investitori.
BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), líder en descubrimiento de medicamentos impulsado por IA, ha anunciado su participación en la 26ª Conferencia Anual Global de Inversión H.C. Wainwright en la ciudad de Nueva York. El CEO de la empresa, Vin Singh, ofrecerá una presentación que estará disponible bajo demanda a partir del 9 de septiembre de 2024, a las 7:00 a.m. ET. Las partes interesadas pueden acceder a las transmisiones en vivo y grabadas del evento a través del sitio web de relaciones con inversionistas de BullFrog AI en investors.bullfrogai.com. Esta participación brinda a la empresa la oportunidad de mostrar sus avances en el descubrimiento de medicamentos impulsado por IA a una audiencia global de inversores.
BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), AI 기반의 약물 발견 분야의 선두주자가, 뉴욕에서 열리는 H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스에 참가한다고 발표했습니다. 회사의 CEO인 Vin Singh는 2024년 9월 9일 오전 7시 ET부터 주문형으로 제공될 발표를 진행할 예정입니다. 관심 있는 분들은 BullFrog AI의 투자자 관계 웹사이트인 investors.bullfrogai.com을 통해 행사에 대한 실시간 및 보관된 웹 방송에 접근할 수 있습니다. 이번 참여는 글로벌 투자자들에게 AI 기반의 약물 발견에서의 발전을 보여줄 수 있는 기회를 제공합니다.
BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), leader dans la découverte de médicaments assistée par l'IA, a annoncé sa participation à la 26e Conférence Annuelle Mondiale sur l'Investissement H.C. Wainwright à New York. Le PDG de la société, Vin Singh, fera une présentation qui sera disponible à la demande à partir du 9 septembre 2024, à 7h00 ET. Les parties intéressées peuvent accéder aux retransmissions en direct et aux archives de l'événement via le site web des relations avec les investisseurs de BullFrog AI à l'adresse investors.bullfrogai.com. Cette participation offre à l'entreprise l'opportunité de présenter ses avancées dans la découverte de médicaments assistée par l'IA à un public mondial d'investisseurs.
BullFrog AI Holdings (NASDAQ: BFRG; BFRGW), ein führendes Unternehmen im Bereich KI-gestützte Medikamentenentdeckung, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz H.C. Wainwright in New York City angekündigt. Der CEO des Unternehmens, Vin Singh, wird eine Präsentation halten, die ab 9. September 2024, 7:00 Uhr ET auf Abruf verfügbar sein wird. Interessierte Parteien können über die Investoren-Website von BullFrog AI unter investors.bullfrogai.com auf Live- und Archivübertragungen der Veranstaltung zugreifen. Diese Teilnahme bietet dem Unternehmen die Möglichkeit, seine Fortschritte in der KI-gestützten Medikamentenentdeckung einem globalen Publikum von Investoren zu präsentieren.
- Participation in a major global investment conference, potentially increasing visibility to investors
- On-demand availability of CEO's presentation, allowing for wider audience reach
- None.
GAITHERSBURG, Md., Aug. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven drug discovery, announced today that the Company will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held in New York City.
Interested parties may access live and archived webcasts of these events on the company’s investor relations website at: investors.bullfrogai.com. The Company’s presentation by Vin Singh, Chief Executive Officer, will be available on demand commencing on September 9, 2024, at 7:00am ET.
About BullFrog AI:
BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials. For more information, visit BullFrog AI at www.bullfrogai.com.
Contact:
Investors
Dave Gentry
RedChip Companies, Inc.
BFRG@redchip.com
1-407-644-4256
SOURCE: BullFrog AI Holdings, Inc.
FAQ
When is BullFrog AI (BFRG) presenting at the H.C. Wainwright Global Investment Conference?
Who will be presenting for BullFrog AI (BFRG) at the investment conference?
How can investors access BullFrog AI's (BFRG) presentation at the H.C. Wainwright conference?
What is BullFrog AI's (BFRG) primary focus in the biotech industry?
